Inclisiran Sodium
Overview
Inclisiran Sodium is a small interfering RNA (siRNA) therapeutic that targets and degrades the mRNA of PCSK9, a protein involved in cholesterol metabolism. It is designed to reduce low-density lipoprotein cholesterol (LDL-C) levels and is used primarily for the treatment of hyperlipidemia.
API suppliers (1)
Suppliers of Inclisiran Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- Yangzhou Aurisco Pharmaceutical Co.,Ltd.China1 active DMF
Therapeutic areas
Do you supply Inclisiran Sodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.